Sign in
CompletedNo phase

Technology Enhanced Adolescent Mental Health (TEAM)

Key facts

Who runs it
University of Notre Dame
Where
South Bend, United StatesSee the site
Trial code
Status
Completed
People taking part
30 people enrolled
Started
6 Sept 2022
Ended
15 Jan 2025
Type of study
Interventional, 2 groups
Treatments tested
  • Non-invasive Transcutaneous Nerve Stimulation (tVNS)
Record updated
17 August 2025

Who can take part

Age
13 years to 17 years
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 11 criteriaShow less

Who can take part

  • Have used alcohol
  • Have engaged in ≥ 3 episodes of NSSI in the past 6 months or ≥ 5 lifetime (1 of these 5 must be in the past year)
  • Own a smartphone (iPhone or Android)

Who cannot take part

  • Have a cardiac pacemaker, implanted defibrillator, or implanted or metallic electronic device
  • Have a history of seizures or epilepsy
  • Temperomandibular Joint Disorder
  • Autism
  • Schizophrenia
  • Pregnant or breastfeeding
  • Bell's Palsy
  • Impaired cranial nerve function or facial pain

Where in United States

  • University of Notre DameSouth Bend, United States

About the trial

What the trial wants to find out

Adolescent nonsuicidal self-injury (NSSI) and alcohol misuse, alone and especially in combination, portend significant functional impairment in adulthood (e.g., relationship dysfunction, depression, suicidality). Although psychosocial interventions for NSSI and substance use are effective for some, they are also expensive and require highly trained clinicians. Treatment is therefore often unavailable to disadvantaged adolescents and those who live rurally. Thus, lower-cost alternative treatments are needed. We will evaluate the efficacy of noninvasive transcutaneous vagus nerve stimulation (tVNS), an effective treatment for depression, in reducing risk for NSSI and substance misuse among vulnerable adolescents.

The 2 groups in the trial

  • Treatment GroupTreatment being tested

    Participants will receive a tVNS device.

    Treatment: Non-invasive Transcutaneous Nerve Stimulation (tVNS)

  • Non-Treatment GroupTreatment being tested

    Participants will not receive a tVNS device.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Leveraging Biomarkers and New Technologies to Reduce Self-Injury and Substance Abuse Risk Among Highly Vulnerable Adolescents
Record updated
17 August 2025